Provide feedbackProvide feedback

Home :: Primary Care

NEJM Report: Redesigning Primary Care

Wednesday, November 19 2008 | Comments
Evidence Grade 12 What's This?

In its Nov. 13, 2008, issue, the New England Journal of Medicine starts a dialogue on a cure for what ails primary care. Featured is a panel discussion moderated by Dr. Thomas Lee, an associate editor of the journal, with 4 experts in primary care and related policy: Drs. Thomas Bodenheimer, Allan Goroll, Barbara Starfield, and Katharine Treadway. In addition, the panelists and Dr. Martin Roland from the United Kingdom provide essays exploring the current crisis in U.S. primary care and...

In its Nov. 13, 2008, issue, the New England Journal of Medicine starts a dialogue on a cure for what ails primary care. Featured is a panel discussion moderated by Dr. Thomas Lee, an associate editor of the journal, with 4 experts in primary care and related policy: Drs. Thomas Bodenheimer, Allan Goroll, Barbara Starfield, and Katharine Treadway. In addition, the panelists and Dr. Martin Roland from the United Kingdom provide essays exploring the current crisis in U.S. primary care and possible solutions for training, practice, compensation, and systemic change.

Read the full report at NEJM online.

Latest News

Food allergies among U.S. children increasingly common, report indicates Verusmed

Wednesday, November 19 2008 | Comments
Evidence Grade 9 What's This?
The prevalence of reported food or digestive allergy among children aged younger than 18 years increased 18% from 1997 to 2007, according to a briefing from the National Center for Health Statistics.

Researchers drew on data from the Centers for Disease Control and Prevention's National Health Interview Survey (NHIS) for their briefing on pediatric food allergy. A multipurpose health...

Metformin offers moderate protection against cardiovascular outcomes, meta-analysis suggests Verusmed

Wednesday, November 19 2008 | Comments
Evidence Grade 2 What's This?
Patients with type 2 diabetes who take metformin hydrochloride may receive moderate protection against adverse cardiovascular outcomes, while rosiglitazone maleate may increase the risk of such events, suggests a new meta-analysis. But researchers caution that large, long-term studies are required to draw firm conclusions about the major clinical benefits and risks related to oral diabetes agents.

The study, conducted by the Johns Hopkins...


OSA identified as novel risk factor for sudden cardiac death Verusmed

Sunday, November 16 2008 | Comments
Evidence Grade 7 What's This?
WATCH VIDEO from AHA

By Selma Kaszczuk

Obstructive sleep apnea (OSA) is an independent predictor of sudden cardiac death (SCD), Dr. Apoor Gami of Midwest Heart Specialists in Elmhurst, Ill., reported, and nocturnal hypoxemia, a hallmark characteristic of OSA, strongly predicts SCD independent of other well-established...

Two studies fail to show benefit of aspirin for primary prevention of cardiovascular events in patients with diabetes Verusmed

Wednesday, November 12 2008 | Comments
Evidence Grade 2 What's This?
Results from 2 new studies do not support the use of aspirin for the primary prevention of cardiovascular events in people with diabetes.

In the first trial, which was conducted in Japan, low-dose aspirin did not seem to prevent cardiovascular events in people with type 2 diabetes, although researchers noted a possible benefit in the older participants.

The prospective, randomized, open-label study enrolled 2,539 individuals aged 30 to 85 years who had type 2...